Theodore G Liou

19PUBLICATIONS
32CO-AUTHORS
Predictive and prognostic markersGene and molecular therapyRespiratory diseasesCarbon capture engineering (excl. sequestration)Epigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jan 19, 2026
An Observational Cohort Study of Targeted Antibiotic Treatments of Cystic Fibrosis Exacerbations.

HollyAnn R Jacobs, Kristyn A Packer, Luis G Vargas Buonfiglio

|Sep 08, 2025
Evaluating Long-Term Effectiveness of Cystic Fibrosis Modulator Therapies after Rapid Adoption: A Dual-Approach Study.

Pedro Miranda Afonso, Grace C Zhou, Weiji Su

|Jul 23, 2024
Impact of Discontinuing Both Hypertonic Saline and Dornase Alfa after Elexacaftor-Tezacaftor-Ivacaftor in Cystic Fibrosis.

Nicole Mayer-Hamblett, Alex H Gifford, Margaret Kloster

|Apr 12, 2024
Predicting weight gain in patients with cystic fibrosis on triple combination modulator.

Kelly L Stewart, Rhonda Szczesniak, Theodore G Liou

|Sep 20, 2023
Mutations in the C-terminal region of the bacteriophage exclusion protein PglX can selectively inactivate restriction in Salmonella.

Christopher E Wozniak, Kelly T Hughes, Theodore G Liou

|Apr 12, 2023
Calibration and validation of modeled 5-year survival predictions among people with cystic fibrosis treated with the cystic fibrosis transmembrane conductance regulator modulator ivacaftor using United States registry data.

Lisa J McGarry, Zahra Bhaiwala, Andrea Lopez

Pageof 4

Frequent Collaborators

5 joint publications

Robert Paine

4 joint publications

Rhonda Szczesniak

3 joint publications

My N Helms

2 joint publications

Kristi Jo Warren